Bonilla-SilvaE. Rethinking racism: toward a structural interpretation. Am Sociol Rev. 1997;62(3):465-480. Accessed July 6, 2021. Available at:https://www.jstor.org/stable/2657316
4.
OpelzG. The benefit of exchanging donor kidneys among transplant centers. N Engl J Med. 1988;318(20):1289-1292. doi: 10.1056/NEJM198805193182001.
5.
Van BurenCTKermanRHLewisRMKahanBD. Letter. Exchanging donor kidneys. N Engl J Med. 1988;319(16):1092-1093. doi: 10.1056/NEJM198810203191613.
6.
HeldPJKahanBDHunsickerLG, et al. The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med. 1994;331(12):765-770. doi: 10.1056/NEJM199409223311203.
7.
RobertsJPWolfeRABragg-GreshamJL, et al. Effective of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med. 2004; 350(6):545-551. doi: 10.1056/NEJMoa025056.
HanawayMJMacLennanPALockeJE. Exacerbating racial disparities in kidney transplant: the consequences of geographic redistribution. JAMA Surg. 2020;155(8):679-681. doi: 10.1001/jamasurg.2020.1455.
10.
KarpSJSegalGPatilDJ. Fixing organ donation: what gets measured, gets fixed. JAMA Surg. 2020;155(8):687-688. doi: 10.1010/ja,asurg.2020.0748.
11.
CannonRMJonesCMDavisEGFranklinGAGuptaMShahMB. Patterns of geographic variability in mortality and eligible deaths between organ procurement organizations. Am J Transplant. 2019;19(10):2756-2763. doi: 10.1111/ajt.15390.
12.
SiminoffLAGardinerHMWilson-GendersonMShaferTJ. How inaccurate metrics hide the true potential for organ donation in the United States. Prog Transplant. 2018;28(1):12-18. doi: 10.1177/1526924818757939.
13.
GoldbergDSHalpernSDReesePP. Deceased organ donation consent rates among racial and ethnic minorities and older potential donors. Crit Care Med. 2013;41(2):496-505. doi:10.1097/CCM.0b013e318271198c.
14.
SiminoffLALawrenceRHArnoldRM. Comparison of black and white families’ experiences and perceptions regarding organ donation requests. Crit Care Med. 2003;31(1):146-151. doi: 10.1097/00003246-20031000-00023.
15.
GoldbergDKallanMJFuL, et al. Changing metrics of organ procurement organization performance in order to increase organ donation rates in the United States. Am J Transplant. 2017;17(12):3183-33192. doi: 10.1111/ajt.14391.
16.
SnyderJJMusgroveDZaunD, et al. The Center for Medicare and Medicaid Services’ proposed metrics for recertification of organ procurement organizations: evaluation by the Scientific Registry of Transplant Recipients. Am J Transplant. 2020;20(9):2466-2480. doi: 10.1111/ajt.15842.
17.
DuBayDAIvankovaNHerbyI, et al. Factors perceived to influence the decision for African Americans to become registered organ donors at the department of motorized vehicles. J Natl Med Assoc. 2017;109(4):287-293. doi:10.1016/j.jnma.2017.04.004.
18.
BodenheimerHCJrOkunJM, et al. The impact of race on organ donation authorization discussed in the context of liver transplantation. Trans Am Clin Climatol Assoc. 2012;123:64-78.
19.
LezzoniLI. The risks of risk adjustment. JAMA. 1997;278(19):1600-1607. doi: 10.1001/jama.278.19.1600.
20.
VanderWeeleTJRobinsonWR. On the causal interpretation of race in regressions adjusting for confounding and mediating variables. Epidemiology. 2014;25(4):473-484. doi: 10.1097/EDE.0000000000000105.
21.
VyasDAEisensteinLGJonesDS. Hidden in plain sight – reconsidering the use of race correction in clinical algorithms. N Engl J Med. 2020;383(9):874-882. doi: 10.1056/NEJMms2004740.
22.
SiminoffLAArnoldR. Increasing organ donation in the African-American community: altruism in the face of an untrustworthy system. Ann Intern Med. 1999;130(7):607-609. doi:10.7326/0003-4819-130-7-199904060-00023.
23.
NguyenCAGilstrapLGChernewMEMcWilliamsJMLandonBELandrumMB. Social risk adjustment of quality measures for diabetes and cardiovascular disease in a commercially insured US population. JAMA Netw Open. 2019; 2(3):e190838. doi:10.1001/jamanetworkopen.2019.0838.
